Denali Therapeutics Inc
Biotechnology
Healthcare
DNLI
171 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
13.34
52 week high
31.58
high
13.42
52 week low
0.00
low
12.78
growth
-57.78 %
previous Close
13.32
P/E ratio
market cap
1.96 B
div yield
0
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top